9,10-Di-p-tolylanthracene, 97%, 1g

4-Chloro-2,3-difluorobromobenzene, 97.0%, 1g

1-(4-Cyanopyridin-2-yl)piperidine-4-carboxylic acid, 250mg

(R)-2-((tert-Butoxycarbonyl)(ethyl)amino)propanoic acid, 95%, 250mg

([Ir(dF(CF3ppy)2)(5,5'-CF3-bpy)]PF6, 99.0%, 100mg

2-(4-(Bromomethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

(S)-2-((tert-Butoxycarbonyl)amino)-5-guanidinopentanoic acid, 95.0%, 1g

Ethyl 4-amino-3-bromo-5-nitrobenzoate, 97%, 250mg

1-(2-methylphenyl)-1,4-diazepane acetate, 95.0%, 5g

4-Fluorobenzyl Bromide>97.0%(GC)25g

4,4'-Bis(5-hexyl-2-thienyl)-2,2'-bipyridyl>98.0%(HPLC)(N)200mg

3-(3-Bromo-4-hydroxyphenyl)propanoic acid, 98%, 100mg

2,4-Dichloro-6-fluorophenylboronic acid, 98%, 5g